Skip to main content
. 2021 Apr 13;66:103329. doi: 10.1016/j.ebiom.2021.103329

Fig. 2.

Fig 2

Schematic summary of the current approaches used in the evaluation of different therapeutic efficacy in patients with IBD.

Current approaches used in the evaluation of anti-TNF therapy in patients with IBD are based on multiple clinical parameters e.g., symptom relief, changes of severity evaluated by clinical disease activity and severity index, colonoscopy evaluation with histological examination and laboratory biomarkers.